178 related articles for article (PubMed ID: 30745212)
1. Dopamine transporter imaging for the diagnosis of multiple system atrophy cerebellar type.
Vergnet S; Hives F; Foubert-Samier A; Payoux P; Fernandez P; Meyer M; Dupouy J; Brefel-Courbon C; Ory-Magne F; Rascol O; Tison F; Pavy-Le Traon A; Meissner WG
Parkinsonism Relat Disord; 2019 Jun; 63():199-203. PubMed ID: 30745212
[TBL] [Abstract][Full Text] [Related]
2. Subclinical nigrostriatal dopaminergic denervation in the cerebellar subtype of multiple system atrophy (MSA-C).
Muñoz E; Iranzo A; Rauek S; Lomeña F; Gallego J; Ros D; Santamaría J; Tolosa E
J Neurol; 2011 Dec; 258(12):2248-53. PubMed ID: 21633903
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.
Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M
J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374
[TBL] [Abstract][Full Text] [Related]
4. Patterns of dopamine transporter imaging in subtypes of multiple system atrophy.
Bu LL; Liu FT; Jiang CF; Guo SS; Yu H; Zuo CT; Wu P; Wang J
Acta Neurol Scand; 2018 Aug; 138(2):170-176. PubMed ID: 29573392
[TBL] [Abstract][Full Text] [Related]
5. [(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy.
Varrone A; Marek KL; Jennings D; Innis RB; Seibyl JP
Mov Disord; 2001 Nov; 16(6):1023-32. PubMed ID: 11748733
[TBL] [Abstract][Full Text] [Related]
6. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
Berding G; Brücke T; Odin P; Brooks DJ; Kolbe H; Gielow P; Harke H; Knoop BO; Dengler R; Knapp WH
Nuklearmedizin; 2003 Feb; 42(1):31-8. PubMed ID: 12601452
[TBL] [Abstract][Full Text] [Related]
7. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
Kim YJ; Ichise M; Ballinger JR; Vines D; Erami SS; Tatschida T; Lang AE
Mov Disord; 2002 Mar; 17(2):303-12. PubMed ID: 11921116
[TBL] [Abstract][Full Text] [Related]
8. Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy.
Knudsen GM; Karlsborg M; Thomsen G; Krabbe K; Regeur L; Nygaard T; Videbaek C; Werdelin L
Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1631-8. PubMed ID: 15583914
[TBL] [Abstract][Full Text] [Related]
9. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.
Scherfler C; Seppi K; Donnemiller E; Goebel G; Brenneis C; Virgolini I; Wenning GK; Poewe W
Brain; 2005 Jul; 128(Pt 7):1605-12. PubMed ID: 15817519
[TBL] [Abstract][Full Text] [Related]
10. Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism.
Hastings A; Cullinane P; Wrigley S; Revesz T; Morris HR; Dickson JC; Jaunmuktane Z; Warner TT; De Pablo-Fernández E
Neurology; 2024 Jun; 102(11):e209453. PubMed ID: 38759132
[TBL] [Abstract][Full Text] [Related]
11. 99mTc-TRODAT-1 imaging of multiple system atrophy.
Lu CS; Weng YH; Chen MC; Chen RS; Tzen KY; Wey SP; Ting G; Chang HC; Yen TC
J Nucl Med; 2004 Jan; 45(1):49-55. PubMed ID: 14734673
[TBL] [Abstract][Full Text] [Related]
12. 123I-FP-CIT SPECT Accurately Distinguishes Parkinsonian From Cerebellar Variant of Multiple System Atrophy.
Nicastro N; Garibotto V; Burkhard PR
Clin Nucl Med; 2018 Feb; 43(2):e33-e36. PubMed ID: 29215405
[TBL] [Abstract][Full Text] [Related]
13. Different loss of dopamine transporter according to subtype of multiple system atrophy.
Kim HW; Kim JS; Oh M; Oh JS; Lee SJ; Oh SJ; Chung SJ; Lee CS
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):517-25. PubMed ID: 26384682
[TBL] [Abstract][Full Text] [Related]
14. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
[TBL] [Abstract][Full Text] [Related]
15. Positive DAT-SCAN in SPG7: a case report mimicking possible MSA-C.
Bellini G; Del Prete E; Unti E; Frosini D; Siciliano G; Ceravolo R
BMC Neurol; 2021 Aug; 21(1):328. PubMed ID: 34433436
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Extrastriatal
Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J
J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628
[No Abstract] [Full Text] [Related]
17. 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Antonini A; Benti R; De Notaris R; Tesei S; Zecchinelli A; Sacilotto G; Meucci N; Canesi M; Mariani C; Pezzoli G; Gerundini P
Neurol Sci; 2003 Oct; 24(3):149-50. PubMed ID: 14598060
[TBL] [Abstract][Full Text] [Related]
18. A Retrospective Imaging Evaluation of Presynaptic Dopaminergic Degeneration in Multiple System Atrophy with Levodopa Induced Dyskinesia.
Ueno SI; Oyama G; Kanai K; Hatano T; Shimo Y; Hattori N
Tremor Other Hyperkinet Mov (N Y); 2020 Jun; 10():6. PubMed ID: 32775020
[TBL] [Abstract][Full Text] [Related]
19. Brain MRI of multiple system atrophy of cerebellar type: a prospective study with implications for diagnosis criteria.
Carré G; Dietemann JL; Gebus O; Montaut S; Lagha-Boukbiza O; Wirth T; Kremer S; Namer IJ; Anheim M; Tranchant C
J Neurol; 2020 May; 267(5):1269-1277. PubMed ID: 31938861
[TBL] [Abstract][Full Text] [Related]
20. SPECT study of the nigrostriatal dopaminergic system in Huntington's disease.
Hwang WJ; Yao WJ
J Neuroimaging; 2013 Apr; 23(2):192-6. PubMed ID: 22211920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
